Burcu Yapar Taskoylu

7PUBLICATIONS
41CO-AUTHORS
Predictive and prognostic markersOncology and carcinogenesis not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 30, 2025
Real-World Outcomes of Treatment Approaches and the Impact of Systemic Inflammation Markers on Survival in Patients with Locally Advanced and Metastatic Laryngeal Cancer.

Burçin Çakan Demirel, Semra Taş, Taliha Güçlü Kantar

|Nov 27, 2025
Lymphocyte-Associated Inflammation Markers Predict Bleomycin-Induced Pulmonary Toxicity in Testicular Cancer.

Melek Özdemir, Gamze Gököz Doğu, Burcu Yapar Taşköylü

|Nov 27, 2025
Sarcopenic Obesity and Sarcopenic Visceral Obesity, Calculated Using the Skeletal Muscle İndex and Visceral Fat İndex at the L3 Vertebra Level, Do Not Predict Survival Rates in Endometrial Cancer Patients.

Melek Özdemir, Gamze Gököz Doğu, Burcu Yapar Taşköylü

|Jul 05, 2025
Investıgatıon of ntrk fusıon ın non-small cell lung cancers by ımmunohıstochemıcal and molecular methods.

Ubeydullah Öztürk, Emel Kılıçarslan, Burcu Yapar Taşköylü

|Apr 07, 2023
Role of F-18 FDG PET/CT in Predicting Response to Neoadjuvant Chemotherapy in Invasive Ductal Breast Cancer.

Tarik Sengoz, Yeliz Arman Karakaya, Aziz Gültekin

|Sep 26, 2022
The Effect of Continuing Chemotherapy after Chemoradiotherapy during the Time to Surgery on Tumor Response and Survival for Local Advanced Rectal Cancer.

Atike Gökçen Demiray, Arzu Yaren, Uğur Sungurtekin

Pageof 2

Frequent Collaborators

4 joint publications

Melek Özdemir

4 joint publications

Serkan Değirmencioğlu

4 joint publications

Gamze Gököz Doğu

4 joint publications

Atike Gökçen Demiray